Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Novel Oncogene with Kinase-domain (NOK) is a novel tumor-related gene, coding receptor like protein with a kinase domain.
是一个新的肿瘤相关基因，其结构上与受体蛋白相似，具有一个蛋白激酶结构域。
Objective: to study Somatic mutation of the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR gene) in lung adenocarcinoma patients.
目的：探讨表皮生长因子受体(EGFR)基因酪氨酸激酶域体细胞在肺腺癌患者中突变的相关因素。
It had long been known that the EGFR ligand dimerizes the receptor and that this dimerization converts into an activation of the kinase domain;
人们很早就知道，EGFR配体使受体二聚化，这种二聚化导致激酶结构域的激活；
Anti-KDR McAb(3G9) was used to measure the expression of KDR (kinase insert domain-containing receptor) in T24 cells and tumor tissue by immunofluorescence and immunohistochemistry.
使用抗KDR单克隆抗体（3G9），通过免疫荧光、免疫组化检测KDR在T24细胞及瘤体中的表达；
Anti-KDR McAb(3G9) was used to measure the expression of KDR (kinase insert domain-containing receptor) in T24 cells and tumor tissue by immunofluorescence and immunohistochemistry.
使用抗KDR单克隆抗体（3G9），通过免疫荧光、免疫组化检测KDR在T24细胞及瘤体中的表达；
应用推荐